Caroline L. Benn
Affiliations: | Massachusetts General Hospital, Boston, MA |
Area:
Huntington's diseaseGoogle:
"Caroline Benn"Mean distance: 16.27 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| Gillian P. Bates | grad student | King's College | |
| Jang-Ho J. Cha | post-doc | 2002-2006 | MGH |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Aldous SG, Smith EJ, Landles C, et al. (2024) A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease. Brain : a Journal of Neurology |
| Benn CL, Dawson LA. (2020) Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease. Frontiers in Aging Neuroscience. 12: 242 |
| Landles C, Milton RE, Ali N, et al. (2020) Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington'S Disease Model. Brain Communications. 2: fcaa066 |
| Benn CL, Gibson KR, Reynolds DS. (2020) Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases. Journal of Huntington's Disease |
| Schwartzentruber J, Foskolou S, Kilpinen H, et al. (2017) Molecular and functional variation in iPSC-derived sensory neurons. Nature Genetics |
| Bryant DT, Landles C, Papadopoulou AS, et al. (2017) Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice. Scientific Reports. 7: 11900 |
| Choudhary P, Dodsworth BT, Sidders B, et al. (2015) A FOXM1 Dependent Mesenchymal-Epithelial Transition in Retinal Pigment Epithelium Cells. Plos One. 10: e0130379 |
| Choudhary P, Dodsworth BT, Sidders B, et al. (2015) FOXM1 binds to promoters of proliferation associated genes. Plos One |
| Barsyte-Lovejoy D, Li F, Oudhoff MJ, et al. (2014) (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 12853-8 |
| Mielcarek M, Benn CL, Franklin SA, et al. (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease. Plos One. 6: e27746 |